| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 70 |
| 1 | VENETOCLAX | 39 |
| 2 | IBRUTINIB | 24 |
| 3 | ETANERCEPT | 22 |
| 4 | AMBRISENTAN | 18 |
| 5 | UPADACITINIB | 18 |
| 6 | FOLIC ACID | 17 |
| 7 | INFLIXIMAB | 17 |
| 8 | METHOTREXATE | 14 |
| 9 | METHOTREXATE SODIUM | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OLUTASIDENIB | 2 | 0.0069 |
| 1 | POTASSIUM PHOSPHATE, MONOBASIC AND SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | 1 | 0.0055 |
| 2 | AMMONIUM CHLORIDE | 1 | 0.0040 |
| 3 | TAGRAXOFUSP | 1 | 0.0019 |
| 4 | QUIZARTINIB | 1 | 0.0014 |
| 5 | CUPRIC CHLORIDE | 1 | 0.0013 |
| 6 | PACRITINIB | 4 | 0.0013 |
| 7 | FOSTAMATINIB | 10 | 0.0013 |
| 8 | TEDIZOLID PHOSPHATE | 1 | 0.0012 |
| 9 | TELOTRISTAT ETHYL | 6 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | BCL-2 Inhibitor [EPC] | 39 |
| 1 | Kinase Inhibitor [EPC] | 37 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 32 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 29 |
| 4 | Endothelin Receptor Antagonist [EPC] | 28 |
| 5 | Corticosteroid [EPC] | 26 |
| 6 | Vitamin C [EPC] | 21 |
| 7 | Janus Kinase Inhibitor [EPC] | 19 |
| 8 | Vitamin B12 [EPC] | 18 |
| 9 | Vitamin D [EPC] | 18 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD123 Interaction [EPC] | 1 | 0.0019 |
| 1 | Type I Interferon Receptor Antagonist [EPC] | 3 | 0.0016 |
| 2 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 3 | BCL-2 Inhibitor [EPC] | 39 | 0.0006 |
| 4 | Complement 5a Receptor Antagonist [EPC] | 3 | 0.0004 |
| 5 | Provitamin D2 Compound [EPC] | 12 | 0.0004 |
| 6 | Hemoglobin S Polymerization Inhibitor [EPC] | 7 | 0.0003 |
| 7 | Tetracycline-class Antibacterial [EPC] | 2 | 0.0003 |
| 8 | Soluble Guanylate Cyclase Stimulator [EPC] | 8 | 0.0002 |
| 9 | Ergot Derivative [EPC] | 1 | 0.0002 |